Estrella Immunopharma Inc. (ESLA) — Financial Flexibility Index
Estrella Immunopharma Inc. (ESLA) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of $-177.49K (operating CF $-177.49K minus capex $0.00) represents 0% of total liabilities ($13.54 Million). Also explore ESLA net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Estrella Immunopharma Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Estrella Immunopharma Inc. across 5 annual periods. Check Estrella Immunopharma Inc. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Estrella Immunopharma Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Estrella Immunopharma Inc.. For the full company profile including market capitalisation, see how much is Estrella Immunopharma Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-1.79 Million | $-1.79 Million | $13.54 Million | ▲ +94.8% |
| 2024 | -2.55x | $-7.64 Million | $-7.64 Million | $3.00 Million | ▲ +97.1% |
| 2023 | -88.92x | $-16.07 Million | $-16.07 Million | $180.70K | ▼ -24738.1% |
| 2022 | -0.36x | $-1.04 Million | $-1.04 Million | $2.92 Million | ▼ -48.0% |
| 2021 | -0.24x | $-1.44 Million | $-1.44 Million | $5.96 Million | — |